International Journal of Technology and Applied Science
E-ISSN: 2230-9004
•
Impact Factor: 9.914
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 17 Issue 6
June 2026
Indexing Partners
Formulation and Evaluation of Capsules of using Taagra Extract for Anxiety
| Author(s) | Divya Arjun Ahire, Neha Tongire |
|---|---|
| Country | India |
| Abstract | Anxiety disorders are predominantly managed using synthetic medications, such as benzodiazepines and SSRIs, which often carry risks of severe side effects, tolerance, and chemical dependency. Valeriana wallichii (Tagara), a highly revered herb in traditional Ayurvedic medicine, offers a scientifically backed natural alternative. Its primary active constituent, valerenic acid, gently modulates GABA-A receptors and inhibits GABA transaminase to induce a safe, calming effect. However, translating the raw hydroalcoholic extract of Tagara into a modern pharmaceutical dosage form is significantly challenged by its highly hygroscopic nature, poor powder flowability, pungent odor, and bitter taste. This research aimed to systematically formulate, engineer, and evaluate a standardized oral hard gelatin capsule utilizing Tagara root extract to overcome these physical limitations. A 70:30 ethanol-to-water extraction yielded 13.70% w/w of concentrated crude extract, which was validated through phytochemical screening for essential secondary metabolites, including flavonoids, alkaloids, and saponins. The engineered, free-flowing blend was encapsulated into Size 0 hard gelatin shells. Subsequent pharmacopeial quality control evaluations confirmed the batch met all official standards. The capsules exhibited exceptional weight uniformity (maximum deviation of ±2.74%), rapid in-vitro disintegration (12 minutes and 45 seconds), and a highly efficient dissolution profile, releasing over 85% of the active therapeutic compounds within 45 minutes. Accelerated stability testing (40°C at 75% RH for 12 weeks) further confirmed the formulation's mechanical and physical integrity. Ultimately, this study successfully transformed a challenging botanical extract into a stable, uniform, and patient-compliant pharmaceutical dosage form for the clinical management of anxiety. |
| Keywords | Valeriana wallichii, Tagara extract, anxiety disorders, valerenic acid, hard gelatin capsules, hydroalcoholic extraction, GABA-A receptor modulation, pre-formulation engineering, pharmacopeial evaluation. |
| Field | Medical / Pharmacy |
| Published In | Volume 17, Issue 5, May 2026 |
| Published On | 2026-05-30 |
Share this

CrossRef DOI is assigned to each research paper published in our journal.
IJTAS DOI prefix is
10.71097/IJTAS
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.